Air Liquide Launches an Innovative Product for Anesthesia
Xenon is a colourless and odourless rare gas. It is an extremely minute element of atmospheric air and its therapeutic effects were first noted in 1951. Thanks to its pharmaceutical properties, anesthetists consider xenon an ideal anesthetic with minimal side effects. Indeed numerous studies on patients in selected German and European clinics have been performed since 1998; they proved xenon is absorbed via the respiratory tract and does not affect the metabolism of a patient in any way. Furthermore, xenon has a very strong analgesic effect. Waking up and recovery of the patient following medical surgery can thus be achieved more easily and rapidly..
Other news from the department research and development
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.